Abstract
We examined the presence of WT1-specific mRNA in bone marrow aspirates or peripheral blood samples of 76 children suffered from acute leukemia at diagnosis and / or relapse. Samples were analyzed by RT-PCR. WT1 -specific mRNA was detected in 79% of patients at diagnosis and in 90% of samples at time of relapse.
The WT1 expression in bone marrow was monitored during the clinical course of some patients. The prognostic value and qualification of WT1 expression for monitoring of MRD (minimal residual disease) during chemotherapy must be confirmed. In contrast to other tumor-specific markers the applicability of WT1 gene expression in most cases of acute leukemia is an important advantage.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gashler AL, Bonthron DT, Madden SL, Rauscher FJ III, Collins T, Sukhatme VP (1992) Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms’ tumor suppressor WT1. Proc Natl Acad Sci USA 89:10984–10988
Harrington MA, Konicek B, Song A, Xia X, Fredricks WJ, Rauscher FJ III (1993) Inhibition of colony-stimulating factor-1 promoter activity by the product of the Wilms’ tumor locus. J Biol Chem 268:21271–21275
Drummond IA, Madden SL, Rohwer-Nutter P, Bell GI, Sukhatme VP, Rauscher FJ III (1992) Repression of the insulin-like growth factor II gene by the Wilms’ tumor suppressor WT1. Science 257:674–678
Dey BR, Sukhatme VP, Roberts AB, Sporn MB, Rauscher FJ III, Kim SJ (1994) Repression of the transforming growth factor-bl gene by Wilms’ tumor suppressor WT1 gene product. Endocrinology 8:595–602
Werner H, Shen-Orr Z, Rauscher FJ III, Morris JF, Roberts CT, Leroith D (1995) Inhibition of cellular proliferation by the Wilms’ tumor suppressor WT1 is associated with suppression of insulin-like growth factor I receptor gene expression. Mol Cell Biol 15:3516–3522
Maheswaran S, Park S, Bernard A, Morris JF, Rauscher FJ III, Hill DE, Haber DA (1993) Physical and functional interaction between WT1 and p53 proteins. Proc Natl Acad Sci USA 90:5100–5104
Haber DA, Sohn RL, Buckler AJ, Pelletier J, Call KM, Housman DE (1991) Alternative splicing and genomic structure of the Wilms’ tumor gene WT1. Proc Natl Acad Sci USA 88:9618–9622
Knapp W, Strobl H, Majdic O (1994) Flow cytometric analysis of cell-surface and intracellular antigens in leukemia diagnosis. Cytometry 18:187–198
Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Bio-chem 162:156–159
Miwa H, Beran M, Saunders GF (1992) Expression of the Wilms’ tumor gene (WT1) in human leukemia. Leukemia 6:405–409
Brieger J, Weidmann E, Fenchel K, Mitrou PS, Hoelzer D, Bergmann L (1994) The expression of the Wilms’ tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 8:2138–2143
Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Dohy H, Nakauchi H, Ishidate T, Akiyama T, Kishimoto T (1994) WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84:3071–3079
Menssen HD, Renkl H-J, Rodeck U, Maurer J, Notier M, Schwartz S, Reinhardt R, Thiel E (1995) Presence of Wilms’ tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 9:1060–1067
Patmasiriwat P, Fraizer GC, Kantarjian H, Saunders GF (1996) Expression pattern of WT1 and GATA-1 in AML with chromosome 16q22 abnormalities. Leukemia 10:1127–1133
Baird PN, Simmons PJ (1997) Expression of the Wilms’ tumor gene (WT1) in normal hemopoiesis. Exp Hematol 25:312–320
Schmid D, Heinze G, Linnerth B, Tisljar K, Kusec R, Geissler K, Sillaber C, Laczika K, Mitterbauer M, Zöchbauer S, Mannhalter C, Haas OA, Lechner K, Jäger U, Gaiger A (1997) Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemia. Leukemia 11:639–643
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Niegemann, E., Wehner, S., Schwabe, D., Ebener, U. (2001). Monitoring of Wilms’ Tumor Gene Transcription in Leukemia Patients. In: Büchner, T., Hiddemann, W., Wörmann, B., Schellong, G., Ritter, J., Creutzig, U. (eds) Acute Leukemias VIII. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 40. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-18156-6_17
Download citation
DOI: https://doi.org/10.1007/978-3-642-18156-6_17
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-62109-3
Online ISBN: 978-3-642-18156-6
eBook Packages: Springer Book Archive